Sait Ashina
@SaitAshina
Followers
2K
Following
6K
Statuses
1K
Headache specialist at BIDMC and Harvard Medical School in Boston, MA. Tweets are my own. Retweets are not endorsements.
Boston, MA
Joined March 2018
Excited to share the release of Headache and Facial Pain Medicine! Grateful to all contributors for their amazing work. I hope it’s a valuable resource for all. #HeadacheMedicine #Neurology #MedicalEducation @MHEducation
1
13
58
RT @ihs_official: Do you know how to diagnose nummular headache? According to the ICHD-3, nummular headache is characterized by pain local…
0
5
0
Stigma is a major yet overlooked factor in #migraine burden. The new Migraine-Related Stigma (MiRS) questionnaire, developed from the OVERCOME study of 60,000+ individuals, is a key tool to measure & address this challenge #pain #stigma @HeadacheJournal👇
1
6
17
RT @HeadacheJournal: Open Access: A new validated tool to measure #migraine-related #stigma may be useful to understand determinants of per…
0
9
0
RT @ihs_official: IHC 2025: Making History in Latin America! Join us in São Paulo, 10–13 September 2025, for a groundbreaking event dedica…
0
5
0
RT @HeadacheJournal: Functional imaging study in patients with #TensionTypeHeadache reveals changes in areas implicated in sensory percepti…
0
12
0
RT @ihs_official: Save the date! Join us for the International Headache Congress 2025 in São Paulo, 10-13 September! For the first time in…
0
8
0
RT @ihs_official: 🎉 Happy New Year 2025! 🎉 The International Headache Society wishes you health and happiness in 2025. Together, let’s con…
0
3
0
RT @ihs_official: 🌍 IHC 2025: In Latin America for the first time! Join us in São Paulo from 10-13 September 2025 for a landmark event ded…
0
9
0
Proud to collaborate on a review of #COVID-19’s impact on #migraine care. Disrupted botulinum toxin treatments and delayed care led to worsened outcomes, but #telemedicine and CGRP antagonists helped. We must build resilient systems for future crises 👇
1
4
14
RT @JCephalalgia: November's Editor's Choice @Simona_Sacco_ Worldwide availability of medications for migraine and tension-type headache:…
0
5
0
Honored to join #EHC2024, debating tension-type headache vs. #migraine with Dimos Mitsikostas & Christian Lampl. Also presented on gepants for migraine prevention, with Dr Gil-Gouveia on acute treatment. Exciting discussions & need for more research! #Headache @EHF_Official
0
1
19
RT @ihs_official: Dr. Mario Peres, President-Elect of the International Headache Society, delivered remarkable talks at #EHC2024 and warmly…
0
1
0
Grateful to join my colleagues at the “Mastering Migraine” community event by @miles4migraine in Newton, MA. Engaging discussions on #migraine burden, stigma, treatments, neck pain, mindfulness, etc. #MigraineAwareness
1
5
33
Chronic pain impacts 2B+ people worldwide, with limited treatments. Regenerative medicine, using extracellular vesicle & exosomes, shows promise for reducing inflammation, tissue repair & pain relief. Explore the potential in our latest review! #pain
0
5
15
RT @JCephalalgia: Chronic migraine treatment is challenging. This study explores combining OnabotulinumtoxinA and anti-CGRP monoclonal anti…
0
8
0
RT @JCephalalgia: This research shows that intravenous eptinezumab offers promise for migraine patients who didn’t respond to subcutaneous…
0
12
0
2024 — Miles for Migraine Education Series: Mastering Migraine_Boston @miles4migraine #Boston #Migraine #Education #Headache 👇
0
3
10
RT @Simona_Sacco_: Advancing our approach to migraine prevention requires high-quality, academically led clinical trials.
0
7
0
RT @ihs_official: This research shows that intravenous eptinezumab offers promise for migraine patients who didn’t respond to subcutaneous…
0
15
0